Since my entry when the heads where 5c I believed that ISN was a great story for 2013/14.
I believe Michael Thomas is a great leader for our company. The only thing that could hurt us prematurely is a takeover before 1 dollar.
That said the potential is Massive and I mean massive. Short path to revenue creation - A massive market and a market need for our technology. Get the right regulatory approvals or any partner news and I would not want to be out. Look at drug companies doing phase 2 and 3 and their market caps. There is plenty of room if management plays the ball with a straight bat. Watch the rebound when she goes green.
ISN Price at posting:
26.5¢ Sentiment: Buy Disclosure: Held